A vision without resources is just a dream
With broad and deep experience in pharma and life sciences.
Atos anticipates your needs to maximize your R&D costs through improving operational and process efficiencies while continuing to drive quality, in the shared journey to realizing a healthier world.
We help you accomplish this with a full range of expertise and services to enrich and streamline virtually every process in your research, production and delivery value chain, bringing you expertise combined with best in class innovation.
The result is a streamlined, accelerated and agile innovation pathway to realize your objectives.
HPC in research
Smart Clinical Trials
Digital Twin for Pharma
As seen in IT Healthcare today
Digital Twin for Healthcare
Insights from Atos experts
One of the coolest healthcare concepts I’ve heard about recently is called a digital twin. For those not familiar with the term, it’s basically a virtual model of a process, product, or service.
Leader in secure decarbonized digital
Atos has committed to achieve net-zero carbon emissions by 2035 and aims to pioneer decarbonization by transforming the way digital technologies are designed, developed and used. 77% of our clients have already set emission reduction targets and are requesting a digital partner to redesign business models that are more respectful to the environment.
To strengthen our decarbonization digital solution portfolio and expertise, Atos has acquired EcoAct, an internationally recognized climate strategy consulting firm. It is estimated 250,000 people a year will die because of climate change by 2030 – we want to help you save lives today, whilst protecting the lives of tomorrow.
Digital Transformation: a catalyst for innovation at Philips
“Atos is a great company to work with, to run and outsource our life support systems…they’re bringing great value to Philips”
- Guaranteed cost reduction
- Assured application as a service
- Over 100 data centers migrated to the cloud
- AI and automation are helping to drive down incidents by 70% to 80%.